Month: March 2021
-
In-Body Gene Editing Tested as Sickle Cell Treatment
Tests with lab mice show the feasibility of editing genes in blood-forming stem cells in bone marrow as a potential treatment for sickle cell disease.
-
CEPI Funding SARS-CoV-2 Variant Vaccines
CEPI, an international consortium, is funding development of vaccines to protect against SARS-CoV-2 mutations, starting with B.1.351 discovered in Brazil.
-
Trial Shows Electronic Treatments Slow Brain Decline
Results from a clinical trial show treatments of electronic audio and visual impulses slow cognitive and functional decline in people with Alzheimer’s disease.
-
Carb-X Funds Vaccine Against Resistant Staph Infections
An international consortium is funding a vaccine to prevent increasingly resistant Staphylococcus aureus infections found in health care facilities.
-
Multiple Solid-Tumor Immunotherapy Trial Underway
A clinical trial is underway testing an immunotherapy for several types of stubborn solid tumor cancer, based on research in university labs.
-
Tools to Game Effectively on Apple Devices
Here are four tools Apple fans will require to game effectively.
-
Microbe Therapy Maker Expands, Adds Venture Funds
A company providing manufacturing services for microbiome drug developers is expanding its facilities, with an infusion of new venture funds.
-
FDA Authorizes Non-Prescription Covid-19 Test
Food and Drug Administration granted an emergency authorization for a molecular test for SARS-CoV-2 viruses done at home without a prescription.
-
Two Therapies Dropped from NIH Covid-19 Trial
A clinical trial testing multiple treatments for people hospitalized with Covid-19 infections is dropping two therapies for not meeting efficacy standards.
-
Crispr Enables Inhaled Flu, Covid-19 Treatment
A biomedical engineering lab designed and tested in lab animals gene-edited therapies for influenza and Covid-19, inhaled by patients with a home device.